MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer
NCT05127850 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2024-05-08
Summary
This is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a patient-administered mobile app for consultation audio recordings.
Conditions
Interventions
- BEHAVIORAL
-
Consultation audio recording app
Smartphone or tablet mobile application which allows for voice recording
Sponsors & Collaborators
-
Conquer Cancer Foundation
collaborator OTHER -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Daniel Kwon, MD · University of California, San Francisco
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-22
- Primary Completion
- 2024-02-16
- Completion
- 2024-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT02705469 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
NCT06609005 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
NCT06854250 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779 ·Status: RECRUITING ·Phase: PHASE3
-
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
NCT03835533 ·Status: COMPLETED ·Phase: PHASE1
-
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
NCT02881242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
NCT06551324 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Treatment Choice in Patients With Localized Prostate Cancer
NCT01177865 ·Status: UNKNOWN ·Phase: NA
-
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy
NCT04424654 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer
NCT02991911 ·Status: COMPLETED ·Phase: PHASE1
-
Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients
NCT06452212 ·Status: COMPLETED
-
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT06145633 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
NCT04109729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
NCT01244568 ·Status: COMPLETED ·Phase: NA
-
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
NCT02787005 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY
NCT02269982 ·Status: COMPLETED
-
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
NCT05150236 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
NCT01360840 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07287150 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT02711956 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
NCT07189403 ·Status: RECRUITING ·Phase: PHASE1
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer
NCT01487863 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT02905201 ·Status: WITHDRAWN
-
Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer
NCT02278055 ·Status: COMPLETED ·Phase: PHASE2